Serum Calprotectin (S100A8/A9) in Diagnosis, Monitoring, and Prognosis of Rheumatic Diseases
Friday, March 28, at 15:00 GMT / 16:00 CET / 11:00 EDT / 08:00 PDT
Serum calprotectin plays a critical role in the pathogenesis of rheumatoid arthritis (RA), as it triggers chemotaxis, phagocyte migration, and modulation of neutrophils and macrophages. Calprotectin has been found to correlate with disease activity, and may add additional information to that provided by conventional biomarkers such as C-reactive protein (CRP).
This webinar provides an overview of the many options for use of serum calprotectin in adult and pediatric patients suffering from autoinflammatory diseases such as rheumatoid arthritis, Still’s disease, vasculitis, and juvenile idiopathic arthritis (JIA).
Key learning objectives
- Discuss the role of calprotectin as a biomarker in pediatric rheumatic diseases
- Explain the clinical applications of calprotectin in diagnosis, monitoring, and prognosis
- Evaluate how serum calprotectin aids in the diagnosis, monitoring of disease activity, and differentiation between rheumatic diseases and other conditions, such as infections and fever of unknown origin
Who should attend?
Rheumatologists, pediatricians, immunologists, internal medicine, lab directors, and lab managers.
Accreditation statement
SelectScience is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. Attendees of this one-hour webinar are also entitled to 1.0 ACCENT Continuing Education Credits from the ADLM. This activity was planned in accordance with ACCENT® Standards and Policies. Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email education@myadlm.org.
Speakers
Marija Jeluŝić, MD, MSc, PhD, is full professor of pediatrics and vice-chair of the Department of Paediatrics at the University of Zagreb, School of Medicine in Croatia. As principal investigator and co-investigator, she has participated in many national and international projects, has been invited to speak in more than 200 national or international meetings. Her field of clinical and research activity focuses on pediatric rheumatology, with an emphasis on vasculitis (IgA vasculitis) and personalized immunology – genetic and cellular analysis of autoimmune and autoinflammatory diseases. Previous research has resulted in awards from the European and Croatian Pediatric Society, the mentorship of PhD theses (10) and 29 graduated thesis (student's diploma thesis), Work to date includes more than 100 clinical research papers published in peer-reviewed journals and 17 funded research grants, six as principal investigator.
Moderator
